Loading...
Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study.
Kashyap, Sangeeta R Kheniser, Karim Aminian, Ali Schauer, Philip le Roux, Carel Burguera, Bartolome
Kashyap, Sangeeta R
Kheniser, Karim
Aminian, Ali
Schauer, Philip
le Roux, Carel
Burguera, Bartolome
Advisors
Editors
Other Contributors
Departments
Date
2020-03-17
Date Submitted
Keywords
bariatric surgery
Body composition
Canagliflozin
type 2 diabetes
Body composition
Canagliflozin
type 2 diabetes
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Loading...
OSP4-6-255.pdf
Adobe PDF, 1.01 MB
Alternative Titles
Publisher
Abstract
Body mass index (-1.24 kg/m2) and body weight (-3.7 kg) were significantly reduced with canagliflozin therapy versus placebo. There were improvements in body fat composition as denoted by reductions in android (-3.00%) and truncal (-2.67%) fat. Also, there were differences in blood glucose and hemoglobin A1C at 6 months.
Language
en
Citation
ISSN
eISSN
2055-2238
ISBN
DOI
10.1002/osp4.409
PMID
32523714